StreetInsider.com News Articles

Enovis to Host Second Quarter 2026 Results Conference Call on August 6th

Fri, 17 Jul 2026 08:00:00 -0400

Dallas, TX, July 17, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its second quarter 2026 financial results on Thursday, August 6th, 2026 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. The live webcast and a presentation related to the call will be accessible from the "Investors" section of Enovis' website at www.enovis.com.

Conference Call/Webcast Information

Investors can access the live webcast via

Enovis to Host Second Quarter 2026 Results Conference Call on August 6th

Fri, 17 Jul 2026 08:00:00 -0400

Conference Call/Webcast Information

Investors can access the live webcast via

Enovis to Host Second Quarter 2026 Results Conference Call on August 6th

Fri, 17 Jul 2026 08:00:00 -0400

Conference Call/Webcast Information

Investors can access the live webcast via

Enovis to Host Second Quarter 2026 Results Conference Call on August 6th

Fri, 17 Jul 2026 08:00:00 -0400

Conference Call/Webcast Information

Investors can access the live webcast via

Enovis launches CT-RevitL laser therapy system for veterinary use

Mon, 13 Jul 2026 08:30:32 -0400

Enovis Corporation (NYSE: ENOV) announced the U.S. launch of CT-RevitL, a veterinary photobiomodulation (PBM) laser therapy system developed by its Companion Animal Health division, on July 13, 2026.

The system is designed to treat pain, tissue healing, inflammation, and post-operative recovery in animals. CT-RevitL includes a technology called COMPASS, which the company describes as an intelligent treatment guidance system intended to provide calibrated dosing and reduce variability across users.

Companion Animal Health, headquartered in Newark, Delaware, claims to be the U.S. market leader in veterinary therapeutic laser technology and states it has been operating in the segment for more than 15 years.

Enovis™ Companion Animal Health Launches CT-RevitL™, the Next-Generation Laser Therapy System for Veterinary Care

Mon, 13 Jul 2026 08:30:00 -0400

CT-RevitL™ launches in the United States, built on a foundation of 150+ published studies on photobiomodulation (PBM) therapy

Designed to deliver deeper, faster and more consistent therapeutic outcomes for animals

DALLAS, TX, July 13, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology company, today announced the U.S. launch of CT-RevitL™, the next-generation veterinary PBM laser therapy system from its Companion Animal Health business. CT-RevitL delivers enhanced clinical performance, greater mobility and a more intuitive treatment experience for veterinary teams and their patients.

Laser therapy is one

Enovis™ Companion Animal Health Launches CT-RevitL™, the Next-Generation Laser Therapy System for Veterinary Care

Mon, 13 Jul 2026 08:30:00 -0400

CT-RevitL™ launches in the United States, built on a foundation of 150+ published studies on photobiomodulation (PBM) therapy

Designed to deliver deeper, faster and more consistent therapeutic outcomes for animals

Laser therapy is one

Enovis™ Companion Animal Health Launches CT-RevitL™, the Next-Generation Laser Therapy System for Veterinary Care

Mon, 13 Jul 2026 08:30:00 -0400

CT-RevitL™ launches in the United States, built on a foundation of 150+ published studies on photobiomodulation (PBM) therapy

Designed to deliver deeper, faster and more consistent therapeutic outcomes for animals

Laser therapy is one

Enovis™ Companion Animal Health Launches CT-RevitL™, the Next-Generation Laser Therapy System for Veterinary Care

Mon, 13 Jul 2026 08:30:00 -0400

CT-RevitL™ launches in the United States, built on a foundation of 150+ published studies on photobiomodulation (PBM) therapy

Designed to deliver deeper, faster and more consistent therapeutic outcomes for animals

Laser therapy is one

BMO Capital Starts Enovis Corp (ENOV) at Outperform

Wed, 08 Jul 2026 16:13:46 -0400

BMO Capital initiates coverage on Enovis Corp (NYSE: ENOV) with a Outperform rating.

For an analyst ratings summary and ratings history on Enovis Corp click here. For more ratings news on Enovis Corp click here.

Shares of Enovis Corp closed at $25.52 yesterday.

Form SCHEDULE 13G/A Enovis CORP Filed by: AMERICAN CENTURY INVESTMENT MANAGEMENT INC

Wed, 08 Jul 2026 10:52:00 -0400

si-local-file:///var/storage/secattach/20260708/26745899.html

Form SCHEDULE 13G/A Enovis CORP Filed by: AMERICAN CENTURY INVESTMENT MANAGEMENT INC

Wed, 08 Jul 2026 10:52:00 -0400

si-local-file:///var/storage/secattach/20260708/26745899.html

Enovis shares jump after Medicare reverses reimbursement cuts

Mon, 06 Jul 2026 11:09:59 -0400

Investing.com -- Enovis Corp shares rose approximately 11% on Monday following a decision by the Centers for Medicare & Medicaid Services to reverse previously announced reimbursement cuts for the company's non-invasive bone growth stimulators.

Evercore Adds Names to TAP Outperform List

Mon, 06 Jul 2026 06:03:50 -0400